Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Eiji Takeuchi
Kensuke Kondo
Yoshio Okano
Michihiro Kunishige
Yoshihiro Kondo
Naoki Kadota
Hisanori Machida
Nobuo Hatakeyama
Keishi Naruse
Hirokazu Ogino
Hiroshi Nokihara
Tsutomu Shinohara
Yasuhiko Nishioka
机构：
[1] National Hospital Organization Kochi Hospital,Department of Clinical Investigation
[2] Tokushima University,Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences
[3] National Hospital Organization Kochi Hospital,Department of Respiratory Medicine
[4] National Hospital Organization Kochi Hospital,Department of Pathology
[5] Tokushima University,Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Early death; Early mortality factors; Immune checkpoint inhibitors; Lung cancer; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3139 / 3147
页数：8
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Sonam Puri
    Michael Shafique
    Jhanelle E. Gray
    Current Treatment Options in Oncology, 2018, 19
  • [22] Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer
    Wang, Xinan
    Ricciuti, Biagio
    Alessi, Joao, V
    Nguyen, Tom
    Awad, Mark M.
    Lin, Xihong
    Johnson, Bruce E.
    Christiani, David C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (12): : 1761 - 1769
  • [23] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Puri, Sonam
    Shafique, Michael
    Gray, Jhanelle E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [24] Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer
    Hu, Yu-xiong
    Guo, Li-jing
    Lin, Meng-qing
    Lin, Qing-yu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (04): : 161 - 166
  • [25] Immune Checkpoint Inhibitors and Additional Local Treatment in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
    Atmaca, A.
    Wetzel, S.
    Van Kampen, M.
    Salam, S.
    Somuncuoglu, G.
    Veit, S.
    Jaeger, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S357 - S358
  • [26] Patterns of response and progression with immune-checkpoint inhibitor combinations in advanced non-small cell lung cancer
    Brown, Lauren
    Ahn, Julie
    Gee, Harriet
    Nagrial, Adnan
    Hau, Eric
    Da Silva, Ines Pires
    RESPIROLOGY, 2023, 28 : 18 - 19
  • [27] Molecular characterization of resistance to immune checkpoint inhibitor and chemotherapy treatment in advanced non-small cell lung cancer
    Kardos, Jordan
    Correa, Paola
    Kim, Sam
    Wang, Min
    Pan, Yang
    Li, Li
    Patterson, Scott Donald
    Iqbal, Shahed
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer
    Wiest, Nathaniel
    Majeed, Umair
    Seegobin, Karan
    Zhao, Yujie
    Lou, Yanyan
    Manochakian, Rami
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [30] Effect of antibiotic treatment on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer
    Alkan, G.
    Oztas, N. Senturk
    Turna, Z. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1082 - S1082
12345